Milestone Scientific, Inc. (NYSE:MLSS) is a medical device company specializing in the development and commercialization of computer-controlled injection technologies designed to improve the administration of local anesthesia. The company’s flagship product, the STA Single Tooth Anesthesia System, is engineered to deliver precise doses of anesthetic with reduced patient discomfort, thereby simplifying dental procedures and enhancing clinical outcomes. Milestone’s solutions aim to address common challenges in pain management by providing clinicians with tools that combine ergonomic design with advanced fluid-pressure feedback technology.
In addition to the STA system, Milestone has expanded its product portfolio to include the CompuFlo Epidural System, which is indicated for epidural space identification during labor and postoperative pain management. The CompuFlo system utilizes real-time pressure sensing to guide needle placement, promoting accuracy and reducing procedural risks. Through these innovations, Milestone serves a diverse customer base of dental practitioners, oral surgeons, anesthesiologists, and pain management specialists seeking alternatives to traditional syringe-based injections.
Founded in 1994 and headquartered in Livingston, New Jersey, Milestone Scientific has grown its global footprint through strategic partnerships and distribution agreements across North America, Europe, Latin America, and select markets in Asia. The company’s devices have obtained multiple regulatory clearances, including FDA 510(k) authorization, CE marking, and approvals from health authorities in key international territories. Milestone’s presence extends to independent distributors and direct sales teams, enabling targeted support and training for end users.
Under the leadership of Chief Executive Officer Frank H. Falbo, Milestone Scientific continues to invest in research and development initiatives aimed at expanding its surgical and medical portfolios. The company’s research activities focus on refining pressure-sensing technologies and developing next-generation injection systems to meet evolving clinical needs. Milestone also engages in collaborative efforts with academic institutions and industry partners to explore new applications for its core technology, reinforcing its commitment to innovation in minimally invasive anesthesia delivery.
AI Generated. May Contain Errors.
Free MLSS Stock Alerts